• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Japan's Astellas to buy Audentes for $3 billion in gene therapy push

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Dec 03, 2019 at 12:22: AM
via Japan’s Astellas Pharma Inc (4503.T) has agreed to buy Audentes Therapeutics Inc (BOLD.O) for about $3 billion in cash as it seeks to make genetic medicines a key area of growth.

article source
 

<



Similar threads

cafead
Japan&#039;s Astellas says employee indicted by China&#039;s prosecutors
Replies
0
Views
25
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Japan&#039;s Eisai says US introduction of Alzheimer&#039;s drug Leqembi slower than expected
Replies
0
Views
70
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Japan&#039;s Ono Pharma taps Texas startup Shattuck for $227M bifunctional fusion protein deal
Replies
0
Views
60
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
AstraZeneca&#039;s phase 3 heart disease trial hits, teeing up Pfizer showdown in Japan
Replies
0
Views
87
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Japan approves Alzheimer&#039;s treatment Leqembi by Eisai and Biogen
Replies
0
Views
109
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote